April 28, 2025 (MLN): Abbott Laboratories (Pakistan) Restricted (PSX: ABOT) reported a 5.33% improve in internet revenue for the quarter ended March 31, 2025, reaching Rs1.60 billion, in comparison with Rs1.52bn in the identical interval final yr.
The corporate posted robust gross sales, which grew by 8.22% to Rs17.35 billion, up from Rs16.03bn within the corresponding quarter of 2024.
Regardless of a slight decline in the price of gross sales, which dropped by 0.64% to Rs11.5bn, gross revenue surged by 31.26%, amounting to Rs5.84bn.
Working bills noticed a modest improve of 9.91%, reaching Rs3.09bn. Promoting and distribution bills rose by 13.5% to Rs2.72bn, and administrative bills elevated by 12.76% to Rs303m.
The corporate's working revenue climbed by 47.95%, reaching Rs2.76bn, whereas finance prices noticed a big decline of 40.74%, falling to Rs3.95m.
Revenue earlier than tax elevated by 56.12%, totaling Rs2.73bn, and the tax expense surged by 393.23% to Rs1.13bn, impacting the web revenue for the quarter.
The earnings per share (EPS) stood at Rs16.34, reflecting a 5.35% improve from Rs15.51 in the identical interval final yr.
| Assertion of Revenue or Loss for the Quarter Ended March 31, 2025 (Rupees '000) | |||
| Description | Mar-25 | Mar-24 | %Change |
| Gross sales – Internet | 17,346,451 | 16,028,928 | 8.22% |
| Price of Gross sales | (11,504,545) | (11,578,125) | -0.64% |
| Gross Revenue | 5,841,906 | 4,450,803 | 31.26% |
| Promoting & Distribution Bills | (2,721,303) | (2,397,568) | 13.50% |
| Administrative Bills | (303,023) | (268,735) | 12.76% |
| Different Expenses | (321,820) | (177,275) | 81.54% |
| Different Earnings | 260,099 | 255,541 | 1.78% |
| Whole Working Bills | (3,086,047) | (2,807,899) | 9.91% |
| Working Revenue | 2,755,859 | 1,862,706 | 47.95% |
| Finance Price | (3,947) | (6,661) | -40.74% |
| Revenue Earlier than Minimal Tax Differential & Closing Taxes | 2,751,912 | 1,856,045 | 48.27% |
| Minimal Tax Differential | (23,624) | (100,624) | -76.52% |
| Closing Taxes | – | (7902) | |
| Revenue Earlier than Taxation | 2,728,288 | 1,747,579 | 56.12% |
| Taxation | (1,128,615) | (228,819) | 393.23% |
| Internet Revenue for the Interval | 1,599,673 | 1,518,760 | 5.33% |
| Fundamental & Diluted Earnings Per Share (Rs.) | 16.34 | 15.51 | 5.35% |
Copyright Mettis Hyperlink Information
Posted on: 2025-04-28T16:53:23+05:00
The submit Abbott Laboratories data quarterly revenue development appeared first on Mettis World Hyperlink.
#Abbott #Laboratories #data #quarterly #revenue #development
Leave a Reply